The co-founder and CEO of ImmunoChem, Dr. Victor Shifrin, received his PhD from Harvard University, and after post-doctoral training at Dana-Farber Cancer Institute and Brigham and Women Hospital (Immunology) took positions of increasing responsibility at several biotech and pharma companies (EISAI, Surface Logix, CombinatoRx, CureLab) where he focused on drug discovery and development.
Dr. Shifrin has more than 15 years of biotech experience managing R&D, regulatory submissions, and early clinical development of experimental therapeutics, as well as in-licensing intellectual property (IP) from universities and its commercialization.
Dr. Shifrin has more than 15 years of biotech experience managing R&D, regulatory submissions, and early clinical development of experimental therapeutics, as well as in-licensing intellectual property (IP) from universities and its commercialization.
Speaking In
2:00 PM - 2:15 PM
Wednesday, June 7
